CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — Immuneering Corporation today announced the company’s participation in Oppenheimer’s Private Life Sciences Company Call Series taking place virtually August 17-19, 2020.
Immuneering co-founder and chief executive officer, Ben Zeskind, Ph.D., MBA, has been invited to present an overview of the company’s business, drug pipelines, Disease Cancelling Technology and partnering activities followed by a question and answer session.
Details regarding the company’s presentation are as follows:
Event: Oppenheimer’s Private Life Sciences Company Call Series
Date: Tuesday, August 18, 2020
Time: 10:15 a.m. ET